Benorilate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H15NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W1QX9DV96G, chemically known as salicylic acid, acetate, ester with 4-hydroxyacetanilide but generally known as benorilate, which bears US NIH Compound Identifier 21102. European Medicines Agency schedules Benorilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05722MIG. The term BENORILATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules benorilate in its Anatomical Therapeutic Chemical (ATC) Classification. BENORILATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benorilate under HS 29242995 and SITC 51479. As of Q4 2014, BENORILATE remains the US FDA Preferred Term for this commodity. Benorilate bears US NLM identifiers UMLS ID C0005011 and NCI Concept Code C80538. SMILES: CC(=O)NC1=CC=C(C=C1)OC(=O)C2=CC=CC=C2OC(=O)C.